Securities Law, Science, Computers & Technology, Criminal Law

McNulty’s Maxim No. 3 and Response to Allegations of Bribery

by Thomas Fox on 3/26/2013

In a Wall Street Journal (WSJ) article by Chris Matthews, Joe Palazzolo and Shira Ovide, entitled “U.S. Probes Microsoft Bribery Allegations”, they reported that the Department of Justice (DOJ) and Securities and Exchange...more

Three Important Lessons from the FCPA Guidance for Pharmaceutical and Medical Device Companies

by Michael Volkov on 12/5/2012

The US Chamber of Commerce “praised” the FCPA Guidance. The Chamber did not get what it wanted but it had to recognize that the FCPA Guidance was helpful for businesses. The FPCA Guidance provides important information for...more

Profit Counting: The Pfizer FCPA Settlement

by Sheppard Mullin Richter & Hampton LLP on 8/20/2012

On August 8, 2012, the U.S. Department of Justice (“DOJ”) and the U.S. Securities and Exchange Commission (“SEC”) announced agreements with the drug manufacturer Pfizer Inc. to settle allegations that a Pfizer subsidiary had...more

LXBN This Week Ep. 3: Facebook's IPO, Oracle v. Google, POM's "Juice Wars" and U.S. v. Roger Clemens [Video]

by LXBN on 5/29/2012

To see links to all posts mentioned in this episode of LXBN TV, go here: http://bit.ly/KUsP5B __________________ After some time away, and coming at you after the long holiday weekend, we have the third installment of...more

The FCPA in 2011: Five Answers and a Looming Question

by Sheppard Mullin Richter & Hampton LLP on 2/1/2012

The Department of Justice has been warning the Life Sciences industries - pharmaceutical and medical device companies - of its intent to focus "on the application of the Foreign Corrupt Practices Act"...more

Ifrah Law’s Blog Wrap-up, February 19 – March 8

by Jeff Ifrah on 3/13/2011

This is the third of a regular series of posts that summarize and wrap up our latest thoughts that have appeared recently on Ifrah Law’s blogs. 1. Will the Internet Taint a Loughner Verdict? Is it impossible for accused...more

EU Suspends Carbon Trading After Almost $38 Million Stolen

by McDermott Will & Emery on 2/4/2011

The most recent theft of almost US$38 million in EU Emission Trading System carbon credits may shift political support in favor of centralization and abolition of national registries. On January 20, 2011, the European...more

Insider Trading Case Highlights Government Focus on Hedge Fund Activities

by Venable LLP on 11/30/2010

A recent insider trading case against a doctor who was involved in clinical trials of a drug to treat hepatitis and allegedly tipped material, non-public information relating to those trials to a hedge fund manager, is...more

“Expert Networks” Under Investigation: Insider Trading Probe Into The Use of Consultants May “Ensnare” Hedge Funds, Mutual Funds,...

by Ropes & Gray LLP on 11/22/2010

The Wall Street Journal reported on November 20 that a far-ranging insider trading probe into the use of outside expert consultants has the potential to “ensnare consultants, investment bankers, hedge-fund and mutual-fund...more

The SEC’s Insider Trading Case Against a Clinical Trial Physician: Lessons For Physicians, Investors, and Public Companies

by Ropes & Gray LLP on 11/15/2010

On November 2, 2010, the Securities and Exchange Commission (“SEC”) brought an action for insider trading against a physician involved in an investigational drug clinical trial based on the alleged use of confidential...more

Securities Litigation Alert: The Foreign Corrupt Practices Act: The Next Corporate Scandal?

by Fenwick & West LLP on 1/28/2008

As the stock option backdating cases wind down, what will be the next corporate scandal to gain widespread notoriety? It is always difficult to predict what alleged misdeeds will be front page news in the coming years, but...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

Securities Law › Science, Computers & Technology › Criminal Law

McNulty’s Maxim No. 3 and Response to Allegations of Bribery

Three Important Lessons from the FCPA Guidance for Pharmaceutical and Medical Device Companies

Profit Counting: The Pfizer FCPA Settlement

LXBN This Week Ep. 3: Facebook's IPO, Oracle v. Google, POM's "Juice Wars" and U.S. v. Roger Clemens [Video]

The FCPA in 2011: Five Answers and a Looming Question

Ifrah Law’s Blog Wrap-up, February 19 – March 8

EU Suspends Carbon Trading After Almost $38 Million Stolen

Insider Trading Case Highlights Government Focus on Hedge Fund Activities

“Expert Networks” Under Investigation: Insider Trading Probe Into The Use of Consultants May “Ensnare” Hedge Funds, Mutual Funds,...

The SEC’s Insider Trading Case Against a Clinical Trial Physician: Lessons For Physicians, Investors, and Public Companies

Securities Litigation Alert: The Foreign Corrupt Practices Act: The Next Corporate Scandal?

LXBN This Week Ep. 3: Facebook's IPO, Oracle v. Google, POM's "Juice Wars" and U.S. v. Roger Clemens [Video]

Expand Your Reach